A decreased activity of CAT has been measured in temporal cortex of AD patients [33] (and in our analysis as well - Figure 2), and it has been demonstrated that acetyl-carnitine administration can improve the cognitive performance in patients with mild AD [34]. Here, CAT is linked to Alzheimer disease.